MoneyWorks4Me

Ajanta Pharma informs about board meeting

19 Oct 2023 Evaluate
Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 to consider and approve Unaudited Consolidated and Standalone Financial Results for the second quarter and half year ended 30.09.2023.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

3548.80 8.10 (0.23%)
28-Aug-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.50
Dr. Reddys Labs. 1179.20
Cipla 1411.25
Lupin 2158.30
Zydus Lifesciences 1181.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: